Evidence map›Paper›PMID 30120416›Full record

ReviewMolecular psychiatry2019

Endosomal sorting and trafficking, the retromer complex and neurodegeneration.

Alana N Vagnozzi, Domenico Praticò

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. GPCR signaling via cAMP nanodomains.The Biochemical journal · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alana N VagnozziAlzheimer's Center at Temple, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 191040, USA.
Domenico PraticòAlzheimer's Center at Temple, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 191040, USA. praticod@temple.edu.

Funding

Vps35 dysregulation, a mechanism of AD-like neurodegeneration and dementia in Down syndromeRF1AG055707 · NIA · TEMPLE UNIV OF THE COMMONWEALTH · PI PRATICO, DOMENICO · 2017 to 2017
$2.0M
Aging, the retromer complex and the neurobiology of Alzheimer's diseaseRF1AG056689 · NIA · TEMPLE UNIV OF THE COMMONWEALTH · PI PRATICO, DOMENICO · 2017 to 2017
$2.0M
NIA NIH HHS RF1 AG055707NIA NIH HHS RF1 AG056689
6 · The paper itself

Abstract

The retromer is a highly conserved multimeric protein complex present in all eukaryotic cells whose activity is essential for regulating the recycling and retrieval of numerous protein cargos from the endosome to trans-Golgi network or the cell surface. In recent years, molecular and genomic studies have provided evidence that aberrant regulation of endosomal protein sorting and trafficking secondary to a dysfunction of the retromer complex could be implicated in the pathogenesis of several neurodegenerative diseases. Thus, deficiency or mutations in one or more protein components of the retromer leads to increased accumulation of protein aggregates, as well as enhanced cellular neurotoxicity. In this review, we will discuss the structure and function of the retromer complex and its neurobiology, its relevance to key molecules involved in neurodegeneration and the potential role that it plays in the development of two major neurodegenerative disorders, Parkinson's disease and Alzheimer's disease. Finally, we will discuss the viability of targeting the retromer via pharmacological chaperones or genetic approaches to enhance or restore its function as a novel and unifying disease-modifying strategy against these diseases.

Indexed as

Alzheimer DiseaseCell MembraneCell MovementEndosomesHumansNeurodegenerative DiseasesParkinson DiseaseProtein TransportSorting Nexinstrans-Golgi NetworkVesicular Transport ProteinsSorting NexinsVesicular Transport Proteins

Identifiers

PMID30120416
PMCPMC6378136

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.